It is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells. Cizumab 400 mg Injection is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian cancer and cervical cancer.
It is an anticancer medicine which is used to treat various types of cancer such as non-small cell lung cancer, head and neck cancer, liver cancer, bladder cancer, Hodgkin's disease, etc. It is also used in combination with ipilimumab for treating certain cancers such as kidney cancer, colorectal cancer, and advanced skin cancer. This medicine is usually given when cancer has spread to other parts of the body or cannot be removed by surgery.
It is a chemotherapy drug used to treat ovarian, breast and non-small cell lung cancer. It may also be used to treat other cancers such as stomach cancer.
It is best to read this information with our general information about chemotherapy and the type of cancer you have.
Paclitaxel is given into a vein. You usually have it as an outpatient. Or you may have it during a short hospital stay if you are having it with other treatments. Your cancer doctor or nurse will tell you how often you will have it.
Like all chemotherapy drugs, paclitaxel can cause side effects. Some of the side effects can be serious, so it is important to read the detailed information below.
Your healthcare team can give you advice on how to manage any side effects. Tell your doctor or nurse straight away if you: have a temperature feel unwell have severe side effects, including any we do not mention here.
Rarely, side effects may be life-threatening. Your cancer doctor or nurse can explain the risk of these side effects to you.
If you need medical attention for any reason other than cancer, always tell the healthcare staff that you are having this treatment.
It is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Keytruda is used alone or in combination with other medicines to treat certain types of cancer such as:
advanced skin cancer (melanoma or Merkel cell carcinoma);
lung cancer;
small cell lung cancer;
head and neck cancer;
classical Hodgkin lymphoma in adults and children;
primary mediastinal large B-cell lymphoma;
cancer of the kidney, bladder, and urinary tract; liver;
cancer of the cervix or uterus;
advanced stomach cancer if your tumor tests positive for "PD-L1" and has a specific genetic marker (an abnormal "HER2/neu" gene);
a type of cancer called squamous cell carcinoma of the esophagus;
a type of liver cancer called hepatocellular carcinoma, after you have received the medicine sorafenib; a type of kidney cancer called renal cell carcinoma (RCC) when used in combination with the medicine axitinib; or a type of uterine cancer called endometrial carcinoma when used in combination with the medicine lenvatinib.
Keytruda is often given when the cancer has spread to other parts of the body, or cannot be surgically removed, or when other cancer treatments did not work or have stopped working.
It is used in the treatment of breast cancer. It works on the surface of a cancer cell, blocking chemical signals that would otherwise stimulate the uncontrolled growth characteristic of cancer cells. Some people being treated with Perjeta experience side effects such as muscle or joint pain, chills, and rash that should be immediately brought to the attention of the healthcare provider administering treatment.
It is acts as a monoclonal antibody. This drug is relatively new and is used to offer targeted therapy to treat cancer. Ristova (Rituximab) 500Mg Injection only targets cancer cells in the body, thus the drug is less harmful as compared to Ristova (Rituximab) Injection radiation treatment. Ristova (Rituximab) Injection is used to treat chronic lymphocytic leukemia and some types of non-hodgkins lymphoma.
It is used for the treatment of a certain type of cancer of the breast and the stomach that has spread to different parts of the body. It is also used to prevent the relapse of certain cancers. It is either used alone or in a combination with other anti-cancer medications.
It is used in the treatment of non-small cell lung cancer. Crizalk 250mg Capsule should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Doctor may advice for regular monitoring of the liver function while your taking this medicine.
It is a prescription medicine that is used to treat certain kinds of cancer.
LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
LENVIMA is used along with another medicine called everolimus to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, after one course of treatment with another anti-cancer medicine
LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery
It is not known if LENVIMA is safe and effective in children.
It is Indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.
It is a prescription medicine that is used along with prednisone. It is used to treat men with prostate cancer that has spread to other parts of the body. It is not known if it is safe and effective in females or children.
It is indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk castration-sensitive prostate cancer (CSPC).
It is used to treat a certain type of breast cancer (HER2-positive). It works by slowing or stopping the growth of cancer cells. TYKERB is a small molecule that passes through the cell membrane and binds to the part of HER2 found inside the cell1 HER2 inhibition is believed to play a role in interrupting the signaling cascade associated with cell proliferation and tumor growth2 TYKERB inhibits 2 receptors involved in tumor proliferation HER2 and its coreceptor, EGFR resulting in an inhibition of ErbB-driven cell growth as seen in vitro and in various animal models1
It is a prescription medicine used to treat adults who have advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. LYNPARZA is used as maintenance treatment after the cancer has responded to your first treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that LYNPARZA is right for you ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, as maintenance treatment, when the cancer has come back. LYNPARZA is used after the cancer has responded to treatment with platinum-based chemotherapy advanced ovarian cancer with a certain type of abnormal inherited BRCA gene, and have received treatment with 3 or more prior types of chemotherapy medicines. Your healthcare provider will perform a test to make sure that LYNPARZA is right for you.
It is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. TAGRISSO is indicated for the treatment of patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.
It is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.
